Our present results were partly in accordance with a previous study indicating that luteolin inhibited the TLR/MyD88/NF-κB pathway, thereby attenuating MSU crystal-induced gouty arthritis (Shen et al., 2020). This evidence concerns the gene MYD88 and gout.